Great Challenges Await New White House Science Adviser

NAS chief Frank Press says that John Gibbons will have to cope with a host of extremely burdensome social and economic issues Editor's Note: Members of the United States science establishment were generally pleased to hear that John H. Gibbons, former director of the Office of Technology Assessment (OTA), had been chosen to succeed D. Allan Bromley as White House science adviser. Among those who warmly endorsed the president's selection of Gibbons--whose appointment was confirmed on January

Written byFrank Press
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

NAS chief Frank Press says that John Gibbons will have to cope with a host of extremely burdensome social and economic issues Editor's Note: Members of the United States science establishment were generally pleased to hear that John H. Gibbons, former director of the Office of Technology Assessment (OTA), had been chosen to succeed D. Allan Bromley as White House science adviser. Among those who warmly endorsed the president's selection of Gibbons--whose appointment was confirmed on January 28 by the U.S. Senate--was Frank Press, president of the National Academy of Sciences. In the following message, exclusive to The Scientist, Press expresses his confidence that Gibbons is the right man for the job, and that his appointment can be taken as a hopeful sign that the new administration will follow a wise path on matters of science and technology policy. However, Press --who served as White House science adviser under Jimmy ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies